You are here

Article Text

Article menu
Download PDFPDF
Structured abstracts of sentinel articles: Picket
Antenatal betamethasone prevented respiratory distress syndrome in late preterm infants
  1. Helen Moore1,
  2. Vikranth Venugopalan2
  1. 1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK
  2. 2 Department of Neonatology, City Hospital, Birmingham, UK
  1. Correspondence to Dr Helen Moore, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK; hels1813{at}doctors.org.uk

https://doi.org/10.1136/archdischild-2017-313632

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Patients

    Women with singleton pregnancy 34 weeks to 36+5 weeks with high probability of late preterm delivery. Women who had previously had glucocorticoid steroids, or whose delivery was expected within 24 hours, or patients with known fetal anomaly or non-reassuring fetal status, were excluded.

    Intervention

    1429 women randomised to betamethasone and 1402 to placebo. Subsequent management was dictated by clinical condition. The groups were balanced for major factors except age (28.6 years in the betamethasone group vs 27.6 years in the placebo group) and Hispanic ethnic group (28.3% in the betamethasone group vs 32% in the placebo group).

    Outcomes

    Primary outcome: need for respiratory support, stillbirth and neonatal death within the first 72 hours. Secondary outcomes: severe respiratory complications, transient tachypnoea of …

    View Full Text

    Footnotes

    • Provenance and peer review Not commissioned; internally peer reviewed.